Literature DB >> 7044302

Relative avidity of etruscomycin to cholesterol and ergosterol.

P Nedeau, I Gruda, G Medoff, J Brajtburg.   

Abstract

Two methods, biological and spectroscopic, were used to determine the avidity of the polyene antibiotic Etruscomycin for cholesterol and ergosterol. The biological method consisted of measuring the inhibitory potency of both sterols on the Etruscomycin-induced damage to erythrocytes and fungi. The spectroscopic method consisted of recording of series of differential spectra in a number of solvents of different composition. The results obtained showed that cholesterol protected erythrocytes and candida albicans against the damaging action of Etruscomycin more efficiently than ergosterol did and that Etruscomycin-cholesterol complexes were more resistant to interruption by organic solvents than Etruscomycin-ergosterol complexes. These results and their comparison with the results obtained with other polyene antibiotics indicate that Etruscomycin resembles filipin in that it binds more avidly to cholesterol than to ergosterol. This implies that the length of the hydrophobic chain rather than the presence of the amino sugar determines sterol preference. The spectral method that we used can have general application for the quantitative measurement of complex formation between polyenes and sterols.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7044302      PMCID: PMC181938          DOI: 10.1128/AAC.21.4.545

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  13 in total

1.  Antagonism by sterols of the action of amphotericin and filipin on the release of potassium ions from Candida albicans and Mycoplasma mycoides subsp. capri.

Authors:  D B Archer; E F Gale
Journal:  J Gen Microbiol       Date:  1975-09

2.  [Interaction between an antifungal heptaene, amphotericin B and cholesterol in vitro, as detected by circular dichroism and absorption. Influence of temperature].

Authors:  C Ernst; J Lematre; H Rinnert; G Dupont; J Grange
Journal:  C R Seances Acad Sci D       Date:  1979-12-10

Review 3.  Biological activity of polyene antibiotics.

Authors:  S M Hammond
Journal:  Prog Med Chem       Date:  1977

Review 4.  Chemistry and biology of the polyene macrolide antibiotics.

Authors:  J M Hamilton-Miller
Journal:  Bacteriol Rev       Date:  1973-06

5.  Fluorometric investigations of the interaction of polyene antibiotics with sterols.

Authors:  F Schroeder; J F Holland; L L Bieber
Journal:  Biochemistry       Date:  1972-08-01       Impact factor: 3.162

6.  Stopped-flow kinetic and equilibrium studies of filipin 3 binding to sterols.

Authors:  R Bittman; W C Chen; L Blau
Journal:  Biochemistry       Date:  1974-03-26       Impact factor: 3.162

7.  Freeze-fracture ultrastructural alterations induced by filipin, pimaricin, nystatin and amphotericin B in the plasmia membranes of Epidermophyton, Saccharomyces and red complex-induced membrane lesions.

Authors:  Y Kitajima; T Sekiya; Y Nozawa
Journal:  Biochim Biophys Acta       Date:  1976-12-02

8.  Classification of polyene antibiotics according to chemical structure and biological effects.

Authors:  J Kotler-Brajtburg; G Medoff; G S Kobayashi; S Boggs; D Schlessinger; R C Pandey; K L Rinehart
Journal:  Antimicrob Agents Chemother       Date:  1979-05       Impact factor: 5.191

9.  Polyene antibiotic-sterol interactions in membranes of Acholeplasma laidlawii cells and lecithin liposomes. 3. Molecular structure of the polyene antibiotic-cholesterol complexes.

Authors:  B de Kruijff; R A Demel
Journal:  Biochim Biophys Acta       Date:  1974-02-26

10.  The ion permeability induced in thin lipid membranes by the polyene antibiotics nystatin and amphotericin B.

Authors:  A Cass; A Finkelstein; V Krespi
Journal:  J Gen Physiol       Date:  1970-07       Impact factor: 4.086

View more
  1 in total

1.  Probable Mechanism(s) of Antifungal Activity of SJA-95, a Heptaene Polyene Antibiotic.

Authors:  S K Desai; S R Naik
Journal:  Indian J Pharm Sci       Date:  2008 Mar-Apr       Impact factor: 0.975

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.